# Beta Cell Rescue in New Onset Type 1 Diabetes With Efalizumab

> **NCT00737763** · PHASE2 · WITHDRAWN · sponsor: **Emory University**

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** efalizumab
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00737763
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-10
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** drug withdrawn from market
- **Last updated:** 2014-05-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00737763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00737763, "Beta Cell Rescue in New Onset Type 1 Diabetes With Efalizumab". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00737763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*